Corporate ManufacturerCached Profile
GRIFOLS USA
Manufacturer Corporate ID: 100000005420
Subsidiaries Logged: 2 entities
LIFETIME CORPORATE SPEND
$2,575,036
General Payments Aggregated (2021–2025)
Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
Top Funded Physicians
Physicians receiving the highest promotional payments from this corporation.
1. Dr. STEPHEN SCHOLANDMedical Doctor
$129,5842. Dr. FREDRICK MELIK-ABRAHAMIANDoctor of Osteopathy
$108,5203. Dr. BOB GENGMedical Doctor
$101,4254. Dr. RICHARD WASSERMANMedical Doctor
$85,7035. Dr. DOUGLAS HOGARTHMedical Doctor
$77,725Top Promoted Products
Drugs or medical devices receiving the highest marketing backing.
1. XEMBIFY$969,192 (37.6%)
2. PROLASTIN-C LIQUID$702,533 (27.3%)
3. GAMUNEX-C$605,767 (23.5%)
4. HYPERRAB$243,196 (9.4%)
5. THROMBATE III$51,918 (2.0%)
Active Subsidiary Entities
Corporate subsidiaries and brands associated with this manufacturer ID in Open Payments.
GRIFOLS SHARED SERVICES NORTH AMERICA, INC.GRIFOLS USA, LLC
Corporate General Payouts Log
Federal registry records of promotional speaking, consulting, meals, and offsets.
Year:
2025
2025
2024
2023
2022
2021
Querying Open Payments Database
Fetching live CMS.gov records for GRIFOLS USA...